Finance

Lists
T1EV34:BVMF
Teva Pharmaceutical Industries Bdr
၉၈.၁၀ R$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၇, GMT-၃ ၁၃:၃၅:၀၃  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for T1EV34...
Mkt. cap
ဋေ ၄.၇၁ ထ
Avg. vol.
၁၂၇.၀၀
Volume
၀.၀၀
52-wk high
၁၀၁.၉၀ R$
52-wk low
၅၁.၆၀ R$
Shares outstanding
၁၁၆.၅၃ ဋေ
No. of employees
၃ သောင်း
Mkt. cap
ဋေ ၄.၇၁ ထ
Avg. vol.
၁၂၇.၀၀
Volume
၀.၀၀
52-wk high
၁၀၁.၉၀ R$
52-wk low
၅၁.၆၀ R$
Shares outstanding
၁၁၆.၅၃ ဋေ
No. of employees
၃ သောင်း
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၄ နာရီ
Teva schedules third-quarter results for November 3: Teva stock sits 2.02 percent below its high
Chemist+Druggist
Chemist+Druggist
·
ပြီးခဲ့သည့် ၄ နာရီ
RCPharm cuts ties with Israeli drug company Teva
ad-hoc-news.de
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၈ နာရီ
JPMorgan raised target for Teva stock to USD 50.00
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၁၈ နာရီ
Teva leaders will discuss medicines in development and the company's potential over five years.
Profile
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform. Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States. Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America. Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs. Wikipedia
About Teva Pharmaceutical Industries Bdr
CEORichard Francis
Employees၃.၂ သောင်း
Founded၁၉၄၄ ဖေ ၁၃
Headquarters-
Sector-
Websiteteva.co.il
Last report
၂၀၂၆ ဇူ ၂၉
Fiscal period
Q2 2026
၀.၀၂ US$ / ၀.၁၁ US$
-၈၁.၄၆%miss
Revenue / Est. (USD)
၄၁၄.၂၀ ဋေ / ၄၀၂.၉၆ ဋေ
+၂.၇၉%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၄၄၈.၀၀ ဋေ
၄၇၁.၁၀ ဋေ
၃၉၈.၂၀ ဋေ
၄၁၄.၂၀ ဋေ
Cost of goods sold
၂၁၇.၆၀ ဋေ
၂၀၅.၆၀ ဋေ
၂၀၁.၁၀ ဋေ
၁၉၈.၉၀ ဋေ
Cost of revenue
၂၁၇.၆၀ ဋေ
၂၀၅.၆၀ ဋေ
၂၀၁.၁၀ ဋေ
၁၉၈.၉၀ ဋေ
Research and development expenses
၂၅.၆၀ ကုဋေ
၂၆.၇၀ ကုဋေ
၂၂.၂၀ ကုဋေ
၉၇.၀၀ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၉၇.၃၀ ကုဋေ
၁၁၂.၀၀ ဋေ
၁၀၀.၀၀ ဋေ
၁၀၃.၄၀ ဋေ
Operating expense
၁၂၃.၈၀ ဋေ
၁၃၇.၀၀ ဋေ
၁၂၀.၈၀ ဋေ
၁၉၈.၆၀ ဋေ
Total operating expenses
၃၄၁.၄၀ ဋေ
၃၄၂.၆၀ ဋေ
၃၂၁.၉၀ ဋေ
၃၉၇.၅၀ ဋေ
Operating income
၁၀၆.၆၀ ဋေ
၁၂၈.၅၀ ဋေ
၇၆.၃၀ ကုဋေ
၁၆.၇၀ ကုဋေ
Other non operating income
-၂.၇၀ ကုဋေ
-
-၁.၃၀ ကုဋေ
-၆.၉၀ ကုဋေ
EBT including unusual items
၆၄.၈၀ ကုဋေ
၉.၀၀ ကုဋေ
၄၃.၆၀ ကုဋေ
-၄၅.၅၀ ကုဋေ
EBT excluding unusual items
၈၃.၂၀ ကုဋေ
၁၀၇.၅၀ ဋေ
၅၄.၇၀ ကုဋေ
-၅.၇၀ ကုဋေ
Income tax expense
၂၁.၄၀ ကုဋေ
-၃၉.၀၀ ကုဋေ
၆.၇၀ ကုဋေ
၁၂.၁၀ ကုဋေ
Effective tax rate
၃၃.၀၂%
-၄၃၃.၃၃%
၁၅.၃၇%
-၂၆.၅၉%
Other operating expenses
၉.၀၀ သန်း
-၁.၇၀ ကုဋေ
-၁.၄၀ ကုဋေ
-၁.၈၀ ကုဋေ
Net income
၄၃.၃၀ ကုဋေ
၄၈.၀၀ ကုဋေ
၃၆.၉၀ ကုဋေ
-၅၇.၆၀ ကုဋေ
Net profit margin
၉.၆၇%
၁၀.၁၉%
၉.၂၇%
-၁၃.၉၁%
Earnings per share
၀.၇၈
၀.၉၆
၀.၅၃
၀.၀၂
Interest and investment income
-
၉.၂၀ ကုဋေ
-
-
Interest expense
-၂၀.၅၀ ကုဋေ
-၂၈.၀၀ ကုဋေ
-၁၉.၁၀ ကုဋေ
-၁၈.၆၀ ကုဋေ
Net interest expenses
-၂၀.၅၀ ကုဋေ
-၁၈.၈၀ ကုဋေ
-၁၉.၁၀ ကုဋေ
-၁၈.၆၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၁၃၁.၅၀ ဋေ
၁၅၄.၅၀ ဋေ
၁၀၀.၂၀ ဋေ
၄၀.၈၀ ကုဋေ
Gain or loss from assets sale
-
-
-၈.၀၀ သန်း
-၁.၂၀ ကုဋေ
AI content may include mistakes. Learn more
Google အက်ပ်များ